Geron | GERN - Operating Expenses


Geron reported $58.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Amgen USD 5.9B 773M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Cassava Sciences USD 13.55M 1.69M Dec/2025
Cytokinetics USD 196.12M 27.43M Dec/2025
Esperion Therapeutics USD 83.21M 14.06M Dec/2025
Exelixis USD 362.75M 21.35M Dec/2025
Genmab DKK 798M 235M Dec/2025
Geron USD 58.8M 2.31M Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
MacroGenics USD 53.32M 13.68M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Novavax USD 126.2M 23.62M Dec/2025